Sio Capital Management, LLC Aslan Pharmaceuticals LTD Transaction History

Sio Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.78 - $3.41 $387,595 - $742,527	-217,750 Reduced 14.63%	1,270,758 $2.26 Million
Q2 2021 Aug 16, 2021	BUY	$2.5 - $3.72 $100,000 - $148,800	40,000 Added 2.76%	1,488,508 $4.91 Million
Q1 2021 May 14, 2021	BUY	$1.86 - $5.25 $103,888 - $293,233	55,854 Added 4.01%	1,448,508 $4.85 Million
Q4 2020 Feb 16, 2021	BUY	$1.54 - $2.22 $24,178 - $34,854	15,700 Added 1.14%	1,392,654 $2.55 Million
Q2 2020 Aug 14, 2020	BUY	$0.96 - $2.19 $78,761 - $179,674	82,043 Added 6.34%	1,376,954 $2.75 Million
Q1 2020 May 15, 2020	BUY	$0.93 - $2.8 $257,554 - $775,432	276,940 Added 27.21%	1,294,911 $1.32 Million
Q4 2019 Feb 14, 2020	BUY	$0.37 - $5.2 $376,649 - $5.29 Million	1,017,971 New	1,017,971 $2.07 Million

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.